Zhejiang Huakang Pharmaceutical Co., Ltd.
SSE:605077.SS
15.09 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 268.484 | 371.452 | 319.278 | 236.709 | 307.167 | 270.114 | 199.378 | 55.929 | 28.705 |
| Depreciation & Amortization
| 201.153 | 172.841 | 106.477 | 85.222 | 60.085 | 51.607 | 48.603 | 45.251 | 44.581 |
| Deferred Income Tax
| 0 | -1.15 | 23.84 | -3.176 | 19.154 | 10.174 | 7.141 | -0.154 | 4.465 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -352.958 | 44.459 | -135.89 | -31.767 | -25.272 | -25.32 | -99.269 | -43.479 | -4.144 |
| Accounts Receivables
| -393.327 | 14.253 | -159.746 | -40.491 | -28.688 | 9.089 | -89.295 | -17.827 | 20.516 |
| Inventory
| -410.936 | -20.139 | -161.098 | -75 | -8.857 | -52.787 | -55.032 | -37.097 | 4.836 |
| Accounts Payables
| 0 | 51.496 | 161.115 | 86.9 | -6.881 | 8.203 | 37.917 | 11.599 | -33.962 |
| Other Working Capital
| 451.305 | -1.15 | 23.84 | -3.176 | 19.154 | 10.174 | -44.237 | -6.382 | -8.98 |
| Other Non Cash Items
| 29.817 | 31.867 | -17.888 | -25.843 | -6.738 | -15.093 | -7.741 | 22.86 | 23.874 |
| Operating Cash Flow
| 146.496 | 619.469 | 271.977 | 264.321 | 335.242 | 281.308 | 140.972 | 80.561 | 93.015 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -1,429.673 | -690.696 | -539.75 | -360.926 | -252.948 | -132.207 | -121.375 | -16.492 | -25.321 |
| Acquisitions Net
| -53.022 | -527.679 | -21 | -29.666 | 0.435 | 1.83 | 0 | 3 | 0.071 |
| Purchases Of Investments
| -24.5 | -20 | -421.626 | -548.6 | -129.2 | -164.2 | -118.27 | -70.84 | -53.53 |
| Sales Maturities Of Investments
| 43.879 | 67.749 | 505.4 | 499.778 | 141.381 | 195.718 | 138.167 | 51.194 | 36.374 |
| Other Investing Activites
| -122.764 | -135.673 | 540.893 | -815.528 | -108.152 | 12.526 | -15.103 | 5.016 | -6.181 |
| Investing Cash Flow
| -1,586.08 | -1,306.3 | 63.916 | -1,254.942 | -348.484 | -86.333 | -116.582 | -28.122 | -48.586 |
| Financing Activities: | |||||||||
| Debt Repayment
| -115.244 | 1,838.898 | 505.078 | -26.815 | -2.478 | -112.899 | 10.185 | -64.6 | -28.42 |
| Common Stock Issued
| 0 | 77.367 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -196.558 | -173.093 | -97.91 | -116.56 | -52.452 | -26.226 | -46.495 | -23.456 | -22.83 |
| Other Financing Activities
| 1.258 | 76.039 | -15.287 | 1,367.46 | -8.849 | 0.401 | 99.003 | 44.927 | 7.75 |
| Financing Cash Flow
| -310.544 | 1,741.844 | 391.881 | 1,220.302 | -63.779 | -165.293 | 62.694 | -43.13 | -43.5 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 10.667 | 0.862 | 5.022 | -1.943 | -2.271 | 2.361 | 0.592 | -0.498 | 1.2 |
| Net Change In Cash
| -1,739.459 | 1,103.625 | 732.796 | 227.738 | -79.292 | 32.043 | 87.676 | 8.811 | 2.13 |
| Cash At End Of Period
| 387.707 | 2,127.166 | 1,023.542 | 290.745 | 63.008 | 142.3 | 110.257 | 22.581 | 13.77 |